200 related articles for article (PubMed ID: 12324989)
1. Oral combination therapy for type 2 diabetes.
Charpentier G
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S70-6. PubMed ID: 12324989
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
3. [Combination therapy with biguanides].
Sakura H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
[No Abstract] [Full Text] [Related]
4. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Kitaoka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
[No Abstract] [Full Text] [Related]
5. Oral agents in the management of type 2 diabetes mellitus.
Luna B; Feinglos MN
Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
[TBL] [Abstract][Full Text] [Related]
6. Oral pharmacologic management of type 2 diabetes.
Riddle MC
Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of type 2 diabetes.
Hermans MP; Buysschaert M
Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
[No Abstract] [Full Text] [Related]
8. [Current and future aspects of oral antidiabetic agents in type 2 diabetes].
Rybka J
Vnitr Lek; 2001 May; 47(5):285-90. PubMed ID: 11395869
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
10. Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
Inzucchi SE
JAMA; 2002 Jan; 287(3):360-72. PubMed ID: 11790216
[TBL] [Abstract][Full Text] [Related]
11. [Update on new oral treatment for diabetes].
Awad J; Schindel B; Schindel Y
Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
[No Abstract] [Full Text] [Related]
12. Treatment of type 2 diabetes mellitus.
Feinglos MN; Bethel MA
Med Clin North Am; 1998 Jul; 82(4):757-90. PubMed ID: 9706120
[TBL] [Abstract][Full Text] [Related]
13. Combining sulfonylureas and other oral agents.
Riddle M
Am J Med; 2000 Apr; 108 Suppl 6a():15S-22S. PubMed ID: 10764846
[TBL] [Abstract][Full Text] [Related]
14. Targeted glycemic control in type 2 diabetes.
Skyler JS
J Fla Med Assoc; 1998 Aug; 85(2):7-15. PubMed ID: 9782713
[No Abstract] [Full Text] [Related]
15. The use of insulin alone and in combination with oral agents in type 2 diabetes.
Buse JB
Prim Care; 1999 Dec; 26(4):931-50. PubMed ID: 10523468
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic therapy for type 2 diabetes mellitus.
DeFronzo RA
Ann Intern Med; 1999 Aug; 131(4):281-303. PubMed ID: 10454950
[TBL] [Abstract][Full Text] [Related]
17. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus.
Jennings PE
Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853
[TBL] [Abstract][Full Text] [Related]
18. Oral agent therapy in the treatment of type 2 diabetes.
Feinglos MN; Bethel MA
Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564
[No Abstract] [Full Text] [Related]
19. New oral therapies for type 2 diabetes.
Purnell JQ; Hirsch IB
Am Fam Physician; 1997 Nov; 56(7):1835-42. PubMed ID: 9371013
[TBL] [Abstract][Full Text] [Related]
20. [Rosiglitazone: clinical data].
Blickle JF
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
